Summary
This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.
Conditions
Drug Effect
Recruitment Status
Recruiting
Eligibility Criteria
Inclusion Criteria:
supported on ECMO
receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management
Exclusion Criteria:
-none
Intervention
Intervention Type
Intervention Name
Drug
Dexmedetomidine
Drug
Fentanyl
Drug
Midazolam
Drug
Morphine
Gender
All
Min Age
0 Days
Max Age
17 Years
Download Date
July 20, 2023
Principal Investigator
Viviane Nasr
Primary Contact Information
For more information on this trial, visit clinicaltrials.gov.
Contact
For more information and to contact the study team:
Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support
NCT03593408
Viviane Nasr, MD
617-355-6225
viviane.nasr@childrens.harvard.edu